Basic Information
RNALocate ID: | RLID:11003010 |
RNA Symbol: | hsa-miR-193b-3p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-193b |
RNA ID: | miRBase:MIMAT0002819 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002338 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01002339 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002340 | Mitochondrion | Myotube | 27396686 |
RLID:01002341 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002342 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002343 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002344 | Nucleolus | HeLa cells | 23940654 |
RLID:01002345 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11003004 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
RLID:11003005 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11003006 | Exosome | Brain tissue | 23382797 |
RLID:11003007 | Exosome | Plasma | 23663360 |
RLID:11003008 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11003009 | Exosome | Plasma | 24683445 |
RLID:11003011 | Microvesicle | Seminal plasma | 23539611 |
RLID:11003012 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000154 | Exosome | B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Tongue tissue | |
RLID-D:11000486 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-193b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-23139 |
MNDR | hsa-miR-193b-3p | Oral squamous cell carcinoma | MNDR-E-MI-23140 |
MNDR | hsa-miR-193b-3p | Medulloblastoma | MNDR-E-MI-23141 |
MNDR | hsa-miR-193b-3p | Lymphoma | MNDR-E-MI-23142 |
MNDR | hsa-miR-193b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-23143 |
MNDR | hsa-miR-193b-3p | Dermatomyositis | MNDR-E-MI-23144 |
MNDR | hsa-miR-193b-3p | Prostate cancer | MNDR-E-MI-23145 |
MNDR | hsa-miR-193b-3p | Gastric cancer | MNDR-E-MI-23146 |
MNDR | hsa-miR-193b-3p | Alzheimer disease | MNDR-E-MI-23147 |
MNDR | hsa-miR-193b-3p | Intracranial aneurysm | MNDR-E-MI-23148 |
MNDR | hsa-miR-193b-3p | Dysautonomia familial | MNDR-E-MI-23149 |
MNDR | hsa-miR-193b-3p | Myotonic dystrophy | MNDR-E-MI-23150 |
MNDR | hsa-miR-193b-3p | Muscular dystrophy duchenne | MNDR-E-MI-23151 |
MNDR | hsa-miR-193b-3p | Head and neck cancer | MNDR-E-MI-23152 |
MNDR | hsa-miR-193b-3p | Leukemia | MNDR-E-MI-23153 |
MNDR | hsa-miR-193b-3p | Huntington disease | MNDR-E-MI-23154 |
MNDR | hsa-miR-193b-3p | Chorea | MNDR-E-MI-23155 |
MNDR | hsa-miR-193b-3p | Cardiovascular disease | MNDR-E-MI-23156 |
MNDR | hsa-miR-193b-3p | Lung cancer | MNDR-E-MI-23157 |
MNDR | hsa-miR-193b-3p | Fragile x syndrome | MNDR-E-MI-23158 |
MNDR | hsa-miR-193b-3p | Parkinson disease | MNDR-E-MI-23159 |
MNDR | hsa-miR-193b-3p | Basal-like breast cancer | MNDR-E-MI-23160 |
MNDR | hsa-miR-193b-3p | Neuroendocrine neoplasia | MNDR-E-MI-23161 |
MNDR | hsa-miR-193b-3p | Thyroid cancer | MNDR-E-MI-23162 |
MNDR | hsa-miR-193b-3p | Pancreatic cancer | MNDR-E-MI-23163 |
MNDR | hsa-miR-193b-3p | Melanoma | MNDR-E-MI-23164 |
MNDR | hsa-miR-193b-3p | Rectum adenocarcinoma | MNDR-E-MI-23165 |
MNDR | hsa-miR-193b-3p | Colon cancer | MNDR-E-MI-23166 |
MNDR | hsa-miR-193b-3p | Ischemic attack transient | MNDR-E-MI-23167 |
MNDR | hsa-miR-193b-3p | Colon adenocarcinoma | MNDR-E-MI-23168 |
MNDR | hsa-miR-193b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-23169 |
MNDR | hsa-miR-193b-3p | Familial ovarian cancer | MNDR-E-MI-23170 |
MNDR | hsa-miR-193b-3p | Glioblastoma | MNDR-E-MI-23171 |
MNDR | hsa-miR-193b-3p | Glioma | MNDR-E-MI-23172 |
MNDR | hsa-miR-193b-3p | Central nervous system lymphoma | MNDR-E-MI-23173 |
MNDR | hsa-miR-193b-3p | Chordoma | MNDR-E-MI-23174 |
MNDR | hsa-miR-193b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-23175 |
MNDR | hsa-miR-193b-3p | Epilepsy temporal lobe | MNDR-E-MI-23176 |
MNDR | hsa-miR-193b-3p | Osteosarcoma | MNDR-E-MI-23177 |
MNDR | hsa-miR-193b-3p | Inclusion body myositis | MNDR-E-MI-23178 |
MNDR | hsa-miR-193b-3p | Infarction middle cerebral artery | MNDR-E-MI-23179 |
MNDR | hsa-miR-193b-3p | Meningioma | MNDR-E-MI-23180 |
MNDR | hsa-miR-193b-3p | Cervical adenocarcinoma | MNDR-E-MI-23181 |
MNDR | hsa-miR-193b-3p | Gastric adenocarcinoma | MNDR-E-MI-23182 |
MNDR | hsa-miR-193b-3p | Cervical squamous cell carcinoma | MNDR-E-MI-23183 |
MNDR | hsa-miR-193b-3p | Lung squamous cell carcinoma | MNDR-E-MI-23184 |
MNDR | hsa-miR-193b-3p | Non-small cell lung cancer | MNDR-E-MI-23185 |
MNDR | hsa-miR-193b-3p | Lung adenocarcinoma | MNDR-E-MI-23186 |
MNDR | hsa-miR-193b-3p | Thyroid carcinoma | MNDR-E-MI-23187 |
MNDR | hsa-miR-193b-3p | Bladder urothelial carcinoma | MNDR-E-MI-23188 |
MNDR | hsa-miR-193b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-23189 |
MNDR | hsa-miR-193b-3p | Brain stem cancer | MNDR-E-MI-23190 |
MNDR | hsa-miR-193b-3p | Carcinoma renal cell | MNDR-E-MI-23191 |
MNDR | hsa-miR-193b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-23192 |
MNDR | hsa-miR-193b-3p | Renal clear cell carcinoma | MNDR-E-MI-23193 |
MNDR | hsa-miR-193b-3p | Large cell carcinoma | MNDR-E-MI-23194 |
MNDR | hsa-miR-193b-3p | Biliary tract cancer | MNDR-E-MI-23195 |
MNDR | hsa-miR-193b-3p | Cholangiocarcinoma | MNDR-E-MI-23196 |
MNDR | hsa-miR-193b-3p | Esophageal cancer | MNDR-E-MI-23197 |
MNDR | hsa-miR-193b-3p | Oncocytoma | MNDR-E-MI-23198 |
MNDR | hsa-miR-193b-3p | Lung small cell carcinoma | MNDR-E-MI-23199 |
MNDR | hsa-miR-193b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-23200 |
MNDR | hsa-miR-193b-3p | Uveal melanoma | MNDR-E-MI-23201 |
MNDR | hsa-miR-193b-3p | Hepatocellular carcinoma | MNDR-E-MI-23202 |
MNDR | hsa-miR-193b-3p | Familiar ovarian carcinoma | MNDR-E-MI-23203 |
MNDR | hsa-miR-193b-3p | Chronic kidney disease | MNDR-E-MI-23204 |
MNDR | hsa-miR-193b-3p | Hodgkin lymphoma | MNDR-E-MI-23205 |
MNDR | hsa-miR-193b-3p | Burkitt lymphoma | MNDR-E-MI-23206 |
MNDR | hsa-miR-193b-3p | Skin cutaneous melanoma | MNDR-E-MI-23207 |
MNDR | hsa-miR-193b-3p | Skin melanoma | MNDR-E-MI-23208 |
MNDR | hsa-miR-193b-3p | Autosomal dominant polycystic kidney disease | MNDR-E-MI-23209 |
MNDR | hsa-miR-193b-3p | Acute myeloid leukemia | MNDR-E-MI-23210 |
MNDR | hsa-miR-193b-3p | Colorectal cancer | MNDR-E-MI-23211 |
MNDR | hsa-miR-193b-3p | Nasopharynx carcinoma | MNDR-E-MI-23212 |
MNDR | hsa-miR-193b-3p | Multiple myeloma | MNDR-E-MI-23213 |
MNDR | hsa-miR-193b-3p | Nasopharyngeal cancer | MNDR-E-MI-23214 |
MNDR | hsa-miR-193b-3p | Epstein-barr virus infections | MNDR-E-MI-23215 |
MNDR | hsa-miR-193b-3p | Brain injury chronic | MNDR-E-MI-23216 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACTB | Homo sapiens | RR00036852 |
TOP